Condition: Polyneuropathy · Amyloidosis · Sponsor: Universitair Ziekenhuis Brussel
To investigate to what extent chronic axonal length-dependent polyneuropathy (CAP) and/or small-fiber neuropathy (SFN) is part of early non-cardiac manifestations of wild-type TTR cardiac amyloidosis (wtTTR-CA). Consequently, explore whether this could ultimately lead to faster diagnosis and clinical outcome of wild-type TTR cardiac amyloidosis (wtTTR-CA).
This description comes directly from the study's public registry record.
Véronique Bissay, MD,Phd · +32 2 477 68 01 · veronique.bissay@uzbrussel.be
Always discuss trial participation with your own doctor first.
| UZ Brussel | Jette, Belgium Capital City, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05950867